GlassScriptPhysician profile
Deepak Chowdhary
NPI 1306895636
$4,614.36
in general payments reported to CMS, 2019-2025
36 companies · $692 in 2025
The $692 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $578 · 2020: $315 · 2021: $786 · 2022: $902 · 2023: $604 · 2024: $738 · 2025: $692.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,017 · Education: $16.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,017.46 |
| Education | $16.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,446.52 | 2019-2025 | Rinvoq, Skyrizi, Creon |
| Takeda Pharmaceuticals U.S.A., INC. | $373.39 | 2019-2025 | Entyvio |
| Steris Corporation | $373.06 | 2021-2024 | |
| Boston Scientific Corporation | $193.83 | 2019-2022 | |
| Pfizer INC. | $174.40 | 2019-2025 | |
| Novo Nordisk INC | $160.89 | 2022-2023 | |
| Endogastric Solutions, INC | $155.59 | 2019-2024 | Esophyx |
| Madrigal Pharmaceuticals | $155.58 | 2025 | Rezdiffra |
| 3-D Matrix, INC. | $133.55 | 2024 | |
| Gilead Sciences, INC. | $119.72 | 2019-2025 | |
| Genzyme Corporation | $112.38 | 2024-2025 | |
| Lucid Diagnostics INC. | $110.26 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $109.64 | 2020-2023 | Trulance |
| Janssen Pharmaceuticals, INC | $105.35 | 2019 | |
| Janssen Scientific Affairs, LLC | $102.19 | 2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Erbe USA INC | $100.00 | 2019 | |
| Janssen Biotech, INC. | $91.21 | 2019-2023 | Stelara |
| Astrazeneca Pharmaceuticals LP | $87.50 | 2022 | |
| Ironwood Pharmaceuticals, INC | $66.44 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $64.44 | 2020-2024 | Dificid |
| Celltrion USA INC. | $46.71 | 2024-2025 | Vegzelma, Zymfentra |
| Olympus America INC. | $41.52 | 2023-2025 | Endoclot Phs, Visiglide |
| Redhill Biopharma INC. | $29.70 | 2021-2022 | |
| Intercept Pharmaceuticals, INC. | $29.41 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $29.29 | 2022-2025 | Rebyota |
| Celgene Corporation | $28.06 | 2021 | |
| Amgen INC. | $27.71 | 2021-2023 | Avsola, Amjevita |
| Regeneron Healthcare Solutions, INC. | $22.24 | 2024 | Dupixent |
| Sandoz INC. | $18.87 | 2023 | Hyrimoz |
| Braintree Laboratories, INC. | $18.64 | 2022 | |
| Ucb, INC. | $16.64 | 2021 | |
| Phathom Pharmaceuticals, INC. | $16.48 | 2025 | Voquezna |
| Allergan, INC. | $16.23 | 2019 | |
| Nestle Healthcare Nutrition INC. | $13.09 | 2023 | |
| Daiichi Sankyo INC. | $12.95 | 2019 | |
| Intra-Sana Laboratories | $10.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepak Chowdhary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.